Jerome Groopman, a staff writer at The New Yorker since 1998, writes primarily about medicine and biology. He holds the Dina and Raphael Recanati Chair of Medicine at the Harvard Medical School and is the chief of experimental medicine at the Beth Israel Deaconess Medical Center. His research has focussed on the basic mechanisms of cancer and AIDS. He has been a major participant in the development of many AIDS-related therapies, including protease inhibitors, and he is active in regional and national education activities in AIDS and cancer medicine, as well as in the training and education of young scientists in these fields. Recently, he has extended the research infrastructure in genetics and cell biology to studies in lymphoma, myelodysplasia, and leukemia. He is a member of the American Academy of Arts and Sciences and the National Academy of Medicine. He has served on many scientific editorial boards and has published more than a hundred and eighty research articles; his editorials on policy issues have appeared in the Times, The New York Review of Books, and the Wall Street Journal2020欧洲杯体育投注网. Among his books are “” and, most recently, “,” written with Dr. Pamela Hartzband.
- Daily Comment
A New Study Questions the Effectiveness of a Potential “Game Changer” Against the Coronavirus
- Daily Comment
The London Patient and a Plan to End the H.I.V. Epidemic in the United States
A Stunning Breakthrough in the Fight Against a Devastating Blood Disease
What’s Missing from the National Discussion About the Opioid Epidemic
The Real Message of the 2017 Nobel Prize in Physiology or Medicine